LEUPRORELIN
202000894
Phase 3 small_molecule active
Quick answer
LEUPRORELIN for polycystic liver disease is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- polycystic liver disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active